Related Experiment Videos
Leukocyte migration and graft-versus-host disease
Christian A Wysocki1, Angela Panoskaltsis-Mortari, Bruce R Blazar
1Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7295, USA.
Blood
|February 11, 2005
Summary
Graft-versus-host disease (GVHD) involves donor T cells attacking the host after bone marrow transplants. This review explores how chemokines and adhesion molecules drive T cell migration to target organs, offering potential therapeutic targets.
Area of Science:
- Immunology
- Transplantation Biology
Background:
- Graft-versus-host disease (GVHD) is a major complication of allogeneic bone marrow transplantation (allo-BMT).
- Acute GVHD pathogenesis involves donor T cell activation by host antigen-presenting cells (APCs) and subsequent migration to target tissues.
Purpose of the Study:
- To review the role of molecular interactions, specifically chemokines, chemokine receptors, and adhesion molecules, in effector T cell migration during GVHD.
- To discuss potential therapeutic targets for mitigating GVHD-related tissue damage.
Main Methods:
- Review of experimental GVHD models.
- Analysis of molecular mechanisms governing T cell trafficking.
Main Results:
- Activated effector T cells migrate from lymphoid tissues to mucosal sites and parenchymal organs (GI tract, liver, lung, skin).
- Chemokine and chemokine receptor interactions are critical for effector cell migration in GVHD.
- Adhesion molecules also play a significant role in T cell trafficking during GVHD.
Conclusions:
- Molecular interactions mediating effector T cell migration are key targets for GVHD therapy.
- Understanding chemokine roles in T cell activation and migration can inform novel treatment strategies for allo-BMT complications.